Aurora/ EnWave Deal Shows Investors Why Being Dry is a High Priority-THC Therapeutics, Inc.

This Post Was Syndicated Under License Via QuoteMedia

HENDERSON, NV / ACCESSWIRE / May 8, 2019 / If you’re a canna-investor and haven’t been under a rock, you’ve probably heard Aurora Cannabis just invested $10 million in EnWave for their vacuum tech which will help improve the potency and flavor of Aurora’s crop.

Aurora isn’t the only producer in need of this kind of tech, which is why we’re highlighting THC Therapeutics, Inc. (THCT). THCT, very recently, announced that they have received full patent protection for The dHydronator®, which can reduce moisture content of cannabis to 10% in only 10-14 hours (normally it takes up to 14 days). The US patent office accepted ALL 20 claims for The dHydronator®. The dHydronator® also destroys harmful surface contaminants & pathogens. The term of the patent provides 20 years of protection on the scalable intellectual property for The dHydronator®. This is big news from THCT.

Today we are highlighting: THC Therapeutics, Inc. (THCT), GW Pharmaceuticals (GWPH), Tilray, Inc. (TLRY), Green Thumb Industries Inc. (GTBIF), and Aurora Cannabis, Inc. (ACB).

THC Therapeutics, Inc. (THCT) (Market Cap: $128.759M; Share Price: $9.35) has developed a sanitizing herb dryer, The dHydronator®. Their laboratory-proven product is specifically designed for drying and sanitizing freshly harvested cannabis and herbs. THCT’s product has been tested by two independent laboratories. The testing covered over 6 strains and 9 independent tests to confirm the findings. Over the 9 tests and 6 strains, there was a 4% average increase of THC-A*.

The US patent office has accepted ALL 20 claims for The dHydronator®. The company has received full patent protection for the dHydronator®. Start your research today on THCT.

GW Pharmaceuticals (GWPH) (Market Cap: $5.613B; Share Price: $182.73) shares rose after the company posted better-than-expected earnings and announced positive results in a late-stage trial of its Epidiolex drug for another condition that causes seizures. Epidilolex is the first cannabis-based drug to win approval from the U.S. Food and Drug Administration as a treatment for severe forms of childhood epilepsy. The drug is now being tested as a treatment for patients with seizures associated with tuberous sclerosis complex, or TSC.

Tilray, Inc. (TLRY) (Market Cap: $4.571B; Share Price: $47.22) sales grew 204% year over year to CA$20.9 million in Q4 2018. Tilray didn’t break out how much it generated in the recreational market, but its sales were CA$12.9 million in Q3, before recreational sales began. If you assume every dollar of its quarter-over-quarter increase was from the recreational market, then its market share would be about 5%.

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, pharmacies, governments, and hospitals; and for researchers for commercial purposes, and compassionate access and clinical research applications.

Green Thumb Industries Inc. (GTBIF) (Market Cap: $2.238B; Share Price: $13.03638) announced in February ’19 the closing of the acquisition of For Success Holding Company, the Los Angeles-based creator of the lifestyle suite of Beboe branded cannabis products.

One of the largest U.S. multi-state cannabis operators is Green Thumb Industries. Headquartered in Chicago, Illinois, GTI has 11 manufacturing facilities and licenses for 71 retail locations across ten highly regulated U.S. markets. Green Thumb Industries Inc. manufactures and sells various cannabis products in the United States. The company’s cannabis products include flower, concentrates for dabbing and vaporizing, edibles, and topical.

Aurora Cannabis (ACB) (Market Cap: $8.785B; Share Price: $8.60) and Hempco Food and Fiber Inc. announced that the companies have entered into a binding letter agreement in which Aurora will acquire all of the issued and outstanding common shares of Hempco not already owned by Aurora. In consideration of the transaction, Aurora has agreed to pay $1.04 per Hempco Share, payable in common shares of Aurora, reflecting a valuation of approximately C$63.4 million on a fully diluted basis.

Headquartered in Edmonton, Alberta, Canada with funded capacity in excess of 625,000 kg per annum and sales and operations in 24 countries across five continents, Aurora is one of the world’s largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.

Legal Disclaimer:

This article was written by Regal Consulting, LLC (“Regal Consulting”). Regal Consulting has agreed to a three-month term consulting agreement with THCT dated 2/14/18. The agreement calls for 50,000 restricted shares of THCT per month. This agreement has been amended to $20,000 per month, and 55,000 shares per month and extended for twelve months ending 3/18/2020. All payments were made directly by THC Therapeutics, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspeculators.com to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. THCT was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.

http://www.regalconsultingllc.com/full legal disclaimer/

Full Legal Disclaimer Click Here.

Contact Information:

Company Name: ACR Communication LLC.

Contact Person: Media Manager

Email: [email protected]

Phone: 1-702-720-6310

Country: United States

SOURCE: ACR Communication LLC